Ligand ID: QI9


Drugbank ID:
DB00468
(Quinine)


Indication:
For the treatment of malaria and leg cramps

Get human targets for QI9 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'QI9'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		1q2w 3C-LIKE PROTEASE
(SARSr-CoV)		5 / 9
PHE A 150
GLU A  14
VAL B 125
VAL A 125
LEU B 115
1.73A21.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		1q2w 3C-LIKE PROTEASE
(SARSr-CoV)		5 / 9
PHE B   3
LEU B 282
LEU A 141
SER A 139
VAL B 296
1.62A21.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		1ssk NUCLEOCAPSID PROTEIN
(SARSr-CoV)		5 / 12
TRP A  30
THR A  54
GLY A 125
PHE A  88
GLY A  92
1.75A18.45
20.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		1uj1 3C-LIKE PROTEINASE
(SARSr-CoV)		4 / 7
PHE B   3
LEU B 282
SER B   1
VAL B 296
1.38A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE B1003
LEU B1282
LEU A 141
SER A 139
VAL B1296
1.67A22.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ALA B1007
SER B1113
GLY B1124
GLY A  11
PRO B1009
1.73A22.47
21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE B1150
GLU B1014
VAL A 125
VAL B1125
LEU A 115
1.73A22.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.78A22.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		1zvb E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 9
LEU A  27
GLU B  31
ASP A  28
VAL C  34
VAL C  30
1.78A6.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2a5k 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 9
PHE B 150
GLU B  14
VAL A 125
VAL B 125
LEU A 115
1.73A22.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2a5k 3C-LIKE PEPTIDASE
(SARSr-CoV)		5 / 9
PHE B   3
LEU B 282
LEU A 141
SER A 139
VAL B 296
1.65A22.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		2ajf ACE2
SPIKE PROTEIN
(Homo
sapiens;
SARSr-CoV)		5 / 12
THR F 485
SER F 432
GLY F 482
GLY B 352
LEU B  45
1.72A19.49
23.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2amd 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.51A20.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2amq 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE B 150
GLU B  14
VAL A 125
VAL B 125
LEU A 115
1.72A20.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 12
ALA B 306
GLY A 317
PHE A 315
GLY A 322
LEU B 354
1.74A17.70
21.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 12
ALA B  39
SER B 129
GLY B  80
PHE B 117
LEU B 110
1.67A20.60
18.92
APR  B 477 (-3.5A)
APR  B 477 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2ghv SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
LEU E 377
LEU C 355
SER E 370
VAL C 497
PHE C 325
1.62A16.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2gri NSP3
(SARSr-CoV)		5 / 9
LEU A  90
SER A  41
THR A  65
VAL A  63
LEU A  66
1.44A13.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2gt7 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.60A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		4 / 7
PHE A 179
LEU A 142
SER A 154
VAL A 148
1.44A21.31
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		2idy NSP3
(SARSr-CoV)		4 / 7
SER A 106
THR A  87
VAL A  58
PHE A  54
1.40A13.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2kaf NSP3
(SARSr-CoV)		5 / 9
SER A  46
THR A  43
VAL A  30
VAL A   7
LEU A  44
1.72A9.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		2ofz NUCLEOCAPSID PROTEIN
(SARS-COV
Tor2)		4 / 7
PHE A 111
SER A  52
THR A 116
VAL A 134
1.37A14.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 9
PHE A 150
GLU A  14
VAL B 125
VAL A 125
LEU B 115
1.72A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 9
PHE B   3
LEU B 282
LEU A 141
SER A 139
VAL B 296
1.69A20.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 7
PHE D 179
LEU D 142
GLU D 145
VAL D 148
1.28A23.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.58A22.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.74A22.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.75A22.13
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2qc2 3C-LIKE PROTEINASE
(-)		5 / 9
PHE B 150
GLU B  14
VAL A 125
VAL B 125
LEU A 115
1.72A21.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		4 / 7
PHE F 179
LEU F 142
SER F 154
VAL F 148
1.36A23.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 9
GLU B 170
THR A 281
VAL B 162
VAL B 172
LEU B 167
1.65A23.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		2vj1 MAIN PROTEINASE
(SARSr-CoV)		5 / 12
HIS A 172
SER A 144
GLY A 170
GLY B   2
LEU A 141
1.74A22.74
21.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		2wct NSP3
(SARSr-CoV)		5 / 12
THR B 502
GLU B 499
GLY B 489
LEU B 471
PRO B 488
1.76A22.63
22.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		3aw1 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.65A21.70
None
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		3bgf F26G19 FAB
(Mus
musculus)		5 / 12
HIS H  35
ALA H  50
GLU H  95
GLY H  96
GLN L  90
1.37A84.62
27.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZNC_A_QI9A301_0
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		3bgf F26G19 FAB
(Mus
musculus)		6 / 9
SER B  82
TYR B  90
VAL B  18
GLU B  81
MET B  80
ASP B  86
1.54A20.45
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		3ea7 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.67A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		3ea7 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE B 150
GLU B  14
VAL A 125
VAL B 125
LEU A 115
1.70A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		3i6g HLA, A-2
MEMBRANE PROTEIN
(Homo
sapiens)		5 / 12
HIS D  70
GLY F   0
PHE D   9
GLY D 100
LEU D 156
1.51A22.61
23.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		3m3s 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.68A21.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.74A19.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.75A19.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		3sci ACE2
(Homo
sapiens)		4 / 7
PHE A 588
LEU A 584
VAL A 447
PHE A 274
1.40A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		3sci ACE2
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)		5 / 12
THR E 485
SER E 432
GLY E 482
GLY A 352
LEU A  45
1.78A22.22
21.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		4 / 7
PHE A 588
LEU A 584
VAL A 447
PHE A 274
1.41A22.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		3sn8 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.67A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		3sn8 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
LEU A  27
THR A  35
VAL A  91
VAL A  68
PHE A  66
1.69A22.34
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		3snd 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
SER B 139
GLY A 215
GLN A 256
GLY A 302
LEU B 141
1.73A22.47
21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		4hi3 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
ALA B 298
SER B 301
GLY A 124
GLY A 138
LEU A 141
1.69A22.36
21.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		4m0w REPLICASE
POLYPROTEIN 1A
UBIQUITIN
(Bos
taurus;
SARSr-CoV)		5 / 9
PHE B  45
LEU B  67
THR A 198
VAL A 188
LEU A 186
1.64A8.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)		5 / 9
PHE A 148
LEU A 133
VAL A 116
VAL A 173
LEU A 113
1.72A22.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE A 150
GLU A  14
VAL B 125
VAL A 125
LEU B 115
1.71A21.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5c5o 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 9
PHE B 150
GLU B  14
VAL A 125
VAL B 125
LEU A 115
1.70A21.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		5c8s GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.73A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5c8s GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		4 / 7
PHE D 183
LEU D 185
THR D 215
PHE C  19
1.39A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		5c8s GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.65A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5c8s GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.71A22.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5c8t GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.64A22.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5c8t GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		4 / 7
PHE D 183
LEU D 185
THR D 215
PHE C  19
1.33A22.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		5c8t GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.58A22.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		5c8t GUANINE-N7
METHYLTRANSFERASE
NSP10
(SARSr-CoV)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE A  19
1.67A22.47
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
TRP B 247
ALA B 281
GLY B 248
GLN B 259
LEU B 253
1.62A18.54
17.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5e6j REPLICASE
POLYPROTEIN 1AB
UBIQUITIN
(SARSr-CoV;
synthetic
construct)		5 / 9
PHE E  45
LEU E  67
THR D 198
VAL D 188
LEU D 186
1.67A8.56
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 9
PHE D 183
LEU D 185
THR D 215
VAL D 236
PHE O  19
1.74A22.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
TRP A 159
GLY A 156
GLY A  93
LEU A 109
PRO A 106
1.70A18.83
18.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 9
PHE B 183
LEU B 185
THR B 215
VAL B 236
PHE N  19
1.79A22.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
TRP C 247
ALA C 281
GLY C 248
GLN C 259
LEU C 253
1.58A18.44
17.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
PHE A   3
LEU A 282
SER A   1
VAL A 296
1.57A14.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
LEU A 978
SER A 728
THR C 533
VAL A 958
PHE C 558
1.65A17.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
THR B 302
SER C 750
GLY B 579
GLY B 634
LEU C 843
1.76A10.63
11.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
LEU A 978
SER A 728
THR C 533
VAL A 958
PHE C 558
1.79A17.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)		4 / 7
PHE B  23
LEU B  19
VAL C  25
PHE C  23
1.39A10.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5x4s SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE A 130
LEU A 132
THR A 160
PHE A 103
LEU A 224
1.73A21.28
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		5x4s SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA A  91
GLU A 184
GLY A 199
GLY A 212
PRO A 210
1.67A20.00
22.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 9
LEU C 978
SER C 728
THR B 533
VAL C 958
PHE B 558
1.52A16.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
SER A 556
GLY B 726
PHE A 578
GLY A 536
PRO A 575
1.70A11.07
11.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 9
LEU C 978
SER C 728
THR B 533
VAL C 958
PHE B 558
1.44A16.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 9
LEU C 978
SER C 728
THR B 533
VAL C 958
PHE B 558
1.50A16.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		4 / 7
PHE A 305
LEU A 615
SER A 577
VAL A 581
1.24A16.69
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5x5f S PROTEIN
(MERS-CoV)		4 / 7
PHE B 164
GLU A 549
SER B 151
VAL B 109
1.26A15.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		5x5f S PROTEIN
(MERS-CoV)		5 / 12
ALA A 113
GLN B 819
GLN A  72
LEU A  74
PRO A 320
1.30A10.95
10.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
LEU B 222
GLU B 162
VAL B 114
PHE B 161
1.26A17.04
LEU  B 222 ( 0.6A)
GLU  B 162 ( 0.5A)
VAL  B 114 ( 0.6A)
PHE  B 161 ( 1.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
ALA A 251
GLY A 255
GLY A 212
LEU A 182
PRO A 210
1.59A10.87
11.77
ALA  A 251 ( 0.0A)
GLY  A 255 ( 0.0A)
GLY  A 212 ( 0.0A)
LEU  A 182 ( 0.6A)
PRO  A 210 ( 1.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		6acd SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE C 238
SER C 239
VAL C 172
VAL C  97
PHE C 138
1.60A16.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE B1044
LEU B1016
THR B1009
VAL B 763
VAL B1042
1.46A16.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
THR A 533
SER C 964
PHE A 316
GLY A 512
LEU A 377
1.79A11.05
11.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
GLY C 953
GLN C 947
GLN B 744
GLY B 739
LEU B 983
1.50A10.79
11.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ack ACE2
(Homo
sapiens)		5 / 12
HIS D 373
ALA D 412
SER D 411
GLY D 377
GLY D 319
1.55A17.57
15.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE B 238
SER B 239
VAL B 172
VAL B  97
PHE B 138
1.61A16.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
LEU A 257
SER A  35
VAL A 186
PHE A  89
1.29A16.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		6ack ACE2
(Homo
sapiens)		5 / 9
PHE D 464
GLU D 457
ASP D 198
VAL D 506
PHE D 512
1.72A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 9
PHE C 130
LEU C 132
THR C 160
PHE C 103
LEU C 224
1.68A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
GLY A 839
GLN C 301
GLN C 599
GLY C 580
LEU A 843
1.75A11.04
11.76
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 7
LEU B 194
SER B 113
THR B 106
PHE B 231
1.44A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
SER C 556
GLY A 726
PHE C 578
GLY C 536
PRO C 575
1.41A11.42
12.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 7
PHE B 130
LEU B 132
THR B 160
PHE B 103
1.21A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 9
PHE C1044
LEU C1016
THR C1009
VAL C 763
VAL C1042
1.52A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6cs0 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
ALA A 864
SER A 861
GLY A 780
PHE A 909
GLN A 786
1.62A11.04
11.76
None
None
None
None
NAG  A1314 (-4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6cs1 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 9
PHE B 130
LEU B 132
THR B 160
PHE B 103
LEU B 224
1.43A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_C_QI9C602_0
(CYTOCHROME P450 2D6)		6cs2 SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 9
LEU A 519
ASP A 518
SER A 516
VAL A 525
PHE A 527
1.77A16.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6iex BETA-2-MICROGLOBULIN
MHC CLASS I ANTIGEN
(Homo
sapiens)		5 / 12
SER B  55
GLY A 237
ARG A 239
PHE A 241
LEU A  32
1.71A18.34
20.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6jyt HELICASE
(SARSr-CoV)		5 / 12
ALA A 487
SER A 517
GLY A 478
GLN A 548
PRO A 514
1.74A19.60
16.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m0j ACE2
(Homo
sapiens)		5 / 9
LEU A 240
THR A 229
VAL A 581
PHE A 523
LEU A 520
1.55A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6m0j SPIKE RECEPTOR
BINDING DOMAIN
(SARS-CoV-2)		5 / 12
THR E 430
SER E 514
GLY E 413
LEU E 425
PRO E 412
1.44A23.53
24.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 9
LEU A 286
LEU A  78
SER A 278
THR A 313
VAL A 306
1.64A21.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 7
PHE A 277
LEU A 494
SER A 278
VAL A 125
1.22A21.60
LEU  A 707 (-3.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
SER C  64
GLY C 397
GLN C 274
GLY C  53
LEU C  61
1.71A15.75
13.69
None
None
None
LEU  C 707 ( 4.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 9
PHE C 255
LEU C 254
VAL C 315
PHE C  74
LEU C  75
1.58A21.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6m18 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 12
SER A  64
ARG A  57
GLY A  53
LEU A  61
PRO A  59
1.53A16.14
16.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m1d ACE2
(Homo
sapiens)		4 / 7
PHE D 588
LEU D 584
VAL D 447
PHE D 274
1.41A18.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6m1d ACE2
(Homo
sapiens)		5 / 12
ALA D 384
GLY D 377
PHE D 555
GLN D 552
GLY D 319
1.50A14.49
14.97
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 7
PHE A   3
LEU A 282
SER A   1
VAL A 296
1.57A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE C 150
GLU C  14
VAL A 125
VAL C 125
LEU A 115
1.69A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE D   3
LEU D 282
LEU B 141
SER B 139
VAL D 297
1.73A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 7
PHE A 159
LEU A  32
SER A 158
VAL A  13
1.60A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE B   3
LEU B 282
LEU D 141
SER D 139
VAL B 297
1.71A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		4 / 7
PHE B   3
LEU B 282
SER B   1
VAL B 296
1.63A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE D 150
GLU D  14
VAL B 125
VAL D 125
LEU B 115
1.71A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
SER D 139
GLY B 215
GLN B 256
GLY B 302
LEU D 141
1.68A22.15

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE C   3
LEU C 282
LEU A 141
SER A 139
VAL C 297
1.70A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE C   3
LEU C 282
LEU A 141
SER A 139
VAL C 296
1.71A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 12
SER C 139
GLY A 215
GLN A 256
GLY A 302
LEU C 141
1.64A22.15

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE D   3
LEU D 282
LEU B 141
SER B 139
VAL D 296
1.74A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE B   3
LEU B 282
LEU D 141
SER D 139
VAL B 296
1.68A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE A   3
LEU A 282
LEU C 141
SER C 139
VAL A 297
1.71A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE A   3
LEU A 282
LEU C 141
SER C 139
VAL A 296
1.68A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m2n 3CL PROTEASE
(SARS-CoV-2)		5 / 9
PHE B 150
GLU B  14
VAL D 125
VAL B 125
LEU D 115
1.73A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m3m NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE B 111
SER B  52
THR B 116
VAL B 134
1.34A16.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
(SARS-CoV-2)		4 / 7
LEU A 187
GLU A 254
THR A 248
PHE A 317
1.38A18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
(SARS-CoV-2)		4 / 7
PHE A 428
LEU A 838
SER A 425
VAL A 880
1.71A18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
(SARS-CoV-2)		4 / 7
SER A 451
THR A 556
VAL A 410
PHE A 442
1.71A18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
(SARS-CoV-2)		4 / 7
PHE A 287
GLU A 254
THR A 246
PHE A 321
1.62A18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6m71 NSP12
(SARS-CoV-2)		5 / 12
ALA A 690
SER A 635
GLY A 679
GLN A 698
GLN A 789
1.69A13.21

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
(SARS-CoV-2)		4 / 7
PHE A 812
LEU A 758
SER A 814
THR A 817
1.69A18.26
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6m71 NSP12
NSP8
(SARS-CoV-2)		5 / 9
LEU B  91
SER A 384
VAL A 330
VAL A 342
LEU B 117
1.36A17.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE A 325
VAL A 497
VAL A 328
PHE A 360
LEU A 421
1.54A17.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 9
PHE B1044
LEU B1016
THR B1009
VAL B 763
VAL B1042
1.54A17.61
None
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
(Homo
sapiens)		5 / 12
ALA H 151
SER H 144
GLY H 148
GLN H 206
LEU H 203
1.73A53.51
27.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
HEAVY CHAIN
S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
LIGHT CHAIN
(Homo
sapiens)		5 / 9
PHE H 180
LEU L 141
VAL L 138
VAL H 195
PHE L 121
1.66A18.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6nur NSP12
NSP8
(SARSr-CoV)		5 / 9
LEU B  91
SER A 384
VAL A 330
VAL A 342
LEU B 117
1.25A17.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZNC_A_QI9A301_0
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		6nur NSP12
(SARSr-CoV)		5 / 9
VAL A 588
GLY A 616
VAL A 763
MET A 756
ASP A 761
1.80A14.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6nur NSP12
(SARSr-CoV)		5 / 12
ALA A 250
GLU A 180
GLN A 210
GLY A 214
LEU A 186
1.63A13.15
12.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6nus NSP12
(SARSr-CoV)		4 / 7
LEU A 187
GLU A 254
THR A 248
PHE A 317
1.28A18.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR B 912
GLY B 908
ARG A1107
GLY A1093
PRO A1090
1.79A11.56
10.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 9
PHE B1062
LEU B1034
THR B1027
VAL B 781
VAL B1060
1.50A16.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 7
LEU A  56
SER A 221
VAL A 193
PHE A  92
1.43A16.75
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY C  35
GLN C 218
GLY C 219
LEU C 189
PRO C 217
1.57A11.88
10.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6vw1 ACE2
(Homo
sapiens)		5 / 9
LEU B 240
THR B 229
VAL B 581
PHE B 523
LEU B 520
1.57A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vw1 ACE2
(Homo
sapiens)		4 / 7
PHE A 588
LEU A 584
VAL A 447
PHE A 274
1.40A21.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vxs NSP3
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vxs NSP3
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vxs NSP3
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vxs NSP3
(SARS-CoV-2)		4 / 7
PHE B 132
LEU B 127
THR A  71
VAL B  96
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 9
LEU C 216
LEU C 223
GLU C 191
VAL C  90
PHE C 192
1.52A16.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
ALA A 222
GLY A 283
PHE C 562
LEU A 277
PRO A  39
1.67A11.72
10.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 7
LEU B  56
GLU B 191
VAL B 193
PHE B 192
1.42A16.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
SER B  94
GLY B  35
GLY B 219
LEU B 189
PRO B 217
1.65A11.23
10.86
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 9
LEU B 216
LEU B 223
GLU B 191
VAL B  90
PHE B 192
1.45A16.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
GLY A  35
PHE A  32
GLY A 219
LEU A 189
PRO A 217
1.67A11.72
10.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 7
PHE C 515
LEU C 517
SER C 514
VAL C 382
1.35A16.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
SER C  94
GLY C  35
GLY C 219
LEU C 189
PRO C 217
1.62A11.23
10.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6vyo NUCLEOPROTEIN
(SARS-CoV-2)		4 / 7
PHE A 110
SER A  51
THR A 115
VAL A 133
1.38A13.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6w02 NSP3
(SARS-CoV-2)		5 / 12
ALA B  38
SER B 128
GLY B  79
PHE B 116
LEU B 109
1.66A20.80
22.07
APR  B 201 (-3.4A)
APR  B 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6w41 SPIKE PROTEIN S1
(SARS-CoV-2)		5 / 12
THR C 430
SER C 514
GLY C 413
LEU C 425
PRO C 412
1.47A23.32
21.95
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 7
PHE H 166
SER L 177
VAL H 181
PHE L 116
1.71A14.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
SPIKE PROTEIN S1
(Homo
sapiens;
SARS-CoV-2)		4 / 7
LEU L  46
SER C 383
THR H  31
VAL H 102
1.69A16.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 7
LEU H 124
SER H 127
THR H 135
VAL H 181
1.79A14.07
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 7
LEU L 175
SER L 159
THR L 180
PHE L 118
1.64A16.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		5 / 9
PHE L 118
LEU L 135
LEU H 189
SER H 127
VAL H 211
1.48A16.25
None
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 12
TRP H  36
ALA H  78
GLY H  49
GLY H  95
LEU H   4
1.45A53.99
22.22
None
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4UIL_H_QI9H1223_0
(FAB 314.1)		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 12
ALA H  78
SER H  21
GLY H  94
PHE H  29
GLY H  26
1.68A53.99
22.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 7
GLU L 161
SER L 159
THR L 180
VAL H 169
1.71A16.25
None
None
None
GOL  L 301 (-4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
PHE A6948
LEU A6978
SER A6943
THR A6934
1.46A
EDO  A7102 (-4.8A)
None
None
KCX  A6935 ( 3.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
PHE A6985
LEU A6981
VAL A6965
PHE A6954
1.74A14.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w6y NSP3
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6w6y NSP3
(SARS-CoV-2)		5 / 12
ALA B  38
SER B 128
GLY B  79
PHE B 116
LEU B 109
1.71A22.22
21.60
MES  B 201 ( 3.4A)
MES  B 201 ( 4.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w6y NSP3
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w6y NSP3
(SARS-CoV-2)		4 / 7
PHE A 168
LEU A  12
SER A 167
VAL A 144
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w6y NSP3
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w75 NSP16
(SARS-CoV-2)		4 / 7
PHE A6985
LEU A6981
VAL A6965
PHE A6954
1.75A15.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w75 NSP16
(SARS-CoV-2)		4 / 7
PHE C6985
LEU C6981
VAL C6965
PHE C6954
1.74A15.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		4 / 7
PHE B 216
LEU B 234
SER B 212
PHE B 241
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6wcf NSP3
(SARS-CoV-2)		5 / 12
ALA A  38
SER A 128
GLY A  79
PHE A 116
LEU A 109
1.67A
MES  A 201 (-3.6A)
MES  A 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wcf NSP3
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wen NSP3
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wey NSP3
(SARS-CoV-2)		4 / 7
PHE A 372
LEU A 216
SER A 371
VAL A 348
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wey NSP3
(SARS-CoV-2)		4 / 7
PHE A 320
LEU A 326
SER A 284
VAL A 351
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
PHE A6985
LEU A6981
VAL A6965
PHE A6954
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE D 110
SER D  51
THR D 115
VAL D 133
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE C  53
LEU C 159
SER C  51
THR C 115
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE B 110
SER B  51
THR B 115
VAL B 133
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE D  53
LEU D 159
SER D  51
THR D 115
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkp NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		4 / 7
PHE B  53
LEU B 159
SER B  51
THR B 115
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wkq NSP16
(SARS-CoV-2)		4 / 7
PHE C6948
LEU C6978
SER C6943
THR C6934
1.54A
FMT  C7105 ( 4.4A)
None
None
FMT  C7104 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
LEU B 134
THR B  99
VAL B 122
PHE B 123
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
PHE B 233
LEU B 251
GLU B 211
VAL B 304
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
PHE A 330
SER A 294
THR A 275
VAL A 321
1.72A
None
U5P  A 401 (-2.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
LEU A 134
THR A  99
VAL A 122
PHE A 123
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
LEU A  73
THR A 145
VAL A 142
PHE A 124
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
PHE A 233
LEU A 251
GLU A 211
VAL A 304
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
LEU B  73
THR B 145
VAL B 142
PHE B 124
1.55A
None
ACT  B 408 (-4.0A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ALA D  38
SER D 128
GLY D  79
PHE D 116
LEU D 109
1.67A
APR  D 201 (-3.2A)
APR  D 201 (-4.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE C 168
LEU C  12
SER C 167
VAL C 144
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE A 168
LEU A  12
SER A 167
VAL A 144
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE C 116
LEU C 122
SER C  80
VAL C 147
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE D 116
LEU D 122
SER D  80
VAL D 147
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ALA A  38
SER A 128
GLY A  79
PHE A 116
LEU A 109
1.67A
APR  A 201 (-3.5A)
APR  A 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ALA C  38
SER C 128
GLY C  79
PHE C 116
LEU C 109
1.68A
APR  C 201 (-3.4A)
APR  C 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE D 168
LEU D  12
SER D 167
VAL D 144
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
ALA B  38
SER B 128
GLY B  79
PHE B 116
LEU B 109
1.67A
APR  B 201 (-3.3A)
APR  B 201 (-4.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
PHE A6985
LEU A6981
VAL A6965
PHE A6954
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 9
LEU B  95
SER C   4
VAL C  11
VAL A  12
LEU C  40
1.67A13.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 9
LEU D  95
SER A   4
VAL A  11
VAL C  12
LEU A  40
1.59A13.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6wrh PEPTIDASE C16
(SARS-CoV-2)		4 / 7
PHE A 216
LEU A 234
SER A 212
PHE A 241
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 9
PHE A   3
LEU A 282
LEU B 141
SER B 139
VAL A 296
1.69A21.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 9
LEU B  95
SER C   4
VAL C  11
VAL A  12
LEU C  40
1.75A11.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 9
LEU D  95
SER A   4
VAL A  11
VAL C  12
LEU A  40
1.78A11.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yi3 NUCLEOPROTEIN
(SARS-CoV-2)		4 / 7
PHE A  70
SER A  11
THR A  75
VAL A  93
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 7
LEU L 181
SER L 165
THR L 186
PHE L 124
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		4 / 7
PHE H 170
SER L 183
VAL H 185
PHE L 122
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR E 430
SER E 514
GLY E 413
LEU E 425
PRO E 412
1.58A22.76
24.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		4 / 7
PHE B 170
SER C 183
VAL B 185
PHE C 122
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla HEAVY CHAIN
LIGHT CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)		4 / 7
LEU C  52
SER A 383
THR B  31
VAL B 108
1.64A
None
DMS  A 905 (-3.9A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 7
GLU C 167
SER C 165
THR C 186
VAL B 173
PHE B 170
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
TRP H  36
ALA H  79
GLY H  49
GLY H  99
LEU H   4
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
GLY H  42
GLN L 106
GLN L   6
GLY L 107
LEU H  45
1.72A
1PE  L1603 ( 4.5A)
None
None
1PE  L1603 (-4.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yla LIGHT CHAIN
(Homo
sapiens)		4 / 7
LEU C 181
SER C 165
THR C 186
PHE C 124
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
GLY B  42
GLN C 106
GLN C   6
GLY C 107
LEU B  45
1.66A
1PE  C 301 (-4.6A)
None
None
1PE  C 301 (-3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
ALA L  86
SER L 174
GLN L  43
GLN L  48
GLY B  26
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
ALA H  79
SER H  21
GLY H  98
PHE H  29
GLY H  26
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
ALA B  79
SER B  21
GLY B  98
PHE B  29
GLY B  26
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR A 430
SER A 514
GLY A 413
LEU A 425
PRO A 412
1.55A22.76
24.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 12
TRP B  36
ALA B  79
GLY B  49
GLY B  99
LEU B   4
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 9
GLU H  16
SER H  85
VAL H 115
VAL H 117
LEU H  18
1.80A17.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 12
TRP H  36
ALA H  79
GLY H  49
GLY H  99
LEU H   4
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 9
PHE H 170
LEU L 142
VAL L 139
VAL H 185
PHE L 122
1.67A17.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 7
GLU L 167
SER L 165
THR L 186
VAL H 173
PHE H 170
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 12
GLY H  42
GLN L 106
GLN L   6
GLY L 107
LEU H  45
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 12
ALA H  79
SER H  21
GLY H  98
PHE H  29
GLY H  26
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR E 430
SER E 514
GLY E 413
LEU E 425
PRO E 412
1.56A22.76
24.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		4 / 7
PHE H 170
SER L 183
VAL H 185
PHE L 122
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_B_QI9B602_0
(CYTOCHROME P450 2D6)		6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)		5 / 9
PHE H 170
LEU L 142
THR L 184
VAL H 185
PHE L 122
1.67A17.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ym0 LIGHT CHAIN
(Homo
sapiens)		4 / 7
LEU L 181
SER L 165
THR L 186
PHE L 124
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
TRP H  36
ALA H  79
GLY H  49
GLY H  99
LEU H   4
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
ALA H  79
SER H  21
GLY H  98
PHE H  29
GLY H  26
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR E 430
SER E 514
GLY E 413
LEU E 425
PRO E 412
1.58A21.19
24.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIN_H_QI9H1226_0
(FAB 314.3)		6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)		5 / 12
THR A 430
SER A 514
GLY A 413
LEU A 425
PRO A 412
1.57A21.19
24.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
TRP B  36
ALA B  79
GLY B  49
GLY B  99
LEU B   4
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
GLY B  42
GLN C 106
GLN C   6
GLY C 107
LEU B  45
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 7
LEU L 181
SER L 165
THR L 186
PHE L 124
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		4 / 7
PHE B 170
SER C 183
VAL B 185
PHE C 122
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yor IGG L CHAIN
(Homo
sapiens)		4 / 7
LEU C 181
SER C 165
THR C 186
PHE C 124
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		5 / 12
GLY H  42
GLN L 106
GLN L   6
GLY L 107
LEU H  45
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)		4 / 7
PHE H 170
SER L 183
VAL H 185
PHE L 122
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6yor IGG H CHAIN
(Homo
sapiens)		5 / 12
ALA B  79
SER B  21
GLY B  98
PHE B  29
GLY B  26
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE E 168
LEU E  12
SER E 167
VAL E 144
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE D 168
LEU D  12
SER D 167
VAL D 144
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 116
LEU C 122
SER C  80
VAL C 147
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE A 168
LEU A  12
SER A 167
VAL A 144
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE D 116
LEU D 122
SER D  80
VAL D 147
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA E  38
SER E 128
GLY E  79
PHE E 116
LEU E 109
1.74A
EPE  E 202 (-3.3A)
EPE  E 202 (-4.6A)
EPE  E 203 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 168
LEU C  12
SER C 167
VAL C 144
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA A  38
SER A 128
GLY A  79
PHE A 116
LEU A 109
1.73A
EDO  A 202 (-3.3A)
EDO  A 202 (-4.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE E 116
LEU E 122
SER E  80
VAL E 147
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE D 116
LEU D 122
SER D  80
VAL D 147
1.60A
None
None
EDO  D 203 (-3.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 116
LEU C 122
SER C  80
VAL C 147
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 168
LEU C  12
SER C 167
VAL C 144
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA E  38
SER E 128
GLY E  79
PHE E 116
LEU E 109
1.67A
APR  E 201 (-3.3A)
APR  E 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE E 168
LEU E  12
SER E 167
VAL E 144
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA D  38
SER D 128
GLY D  79
PHE D 116
LEU D 109
1.70A
APR  D 201 (-3.3A)
APR  D 201 (-4.3A)
EDO  D 203 (-3.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA A  38
SER A 128
GLY A  79
PHE A 116
LEU A 109
1.67A
APR  A 201 (-3.4A)
APR  A 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE E 116
LEU E 122
SER E  80
VAL E 147
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA B  38
SER B 128
GLY B  79
PHE B 116
LEU B 109
1.71A
APR  B 201 (-3.4A)
APR  B 201 (-4.3A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE D 168
LEU D  12
SER D 167
VAL D 144
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA C  38
SER C 128
GLY C  79
PHE C 116
LEU C 109
1.68A
APR  C 201 (-3.4A)
APR  C 201 (-4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA A  38
SER A 128
GLY A  79
PHE A 116
LEU A 109
1.72A
MES  A 201 (-3.5A)
MES  A 201 (-4.4A)
EDO  A 204 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA B  38
SER B 128
GLY B  79
PHE B 116
LEU B 109
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UIL_H_QI9H1223_0
(FAB 314.1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
ALA C  38
SER C 128
GLY C  79
PHE C 116
LEU C 109
1.80A
MES  C 201 (-3.5A)
MES  C 201 (-4.6A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 116
LEU B 122
SER B  80
VAL B 147
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 116
LEU C 122
SER C  80
VAL C 147
1.59A
None
None
EDO  A 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE C 168
LEU C  12
SER C 167
VAL C 144
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE A 168
LEU A  12
SER A 167
VAL A 144
1.60A
None
None
EDO  A 206 ( 4.1A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE A 116
LEU A 122
SER A  80
VAL A 147
1.58A
None
None
EDO  A 204 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
PHE B 168
LEU B  12
SER B 167
VAL B 144
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
PHE A 428
LEU A 838
SER A 425
VAL A 880
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
LEU A 187
GLU A 254
THR A 248
PHE A 317
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
PHE A 859
LEU A 862
VAL A 844
PHE A 843
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		7btf NSP12
NSP8
(SARS-CoV-2)		5 / 9
LEU B  91
SER A 384
VAL A 330
VAL A 342
LEU B 117
1.22A17.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
PHE A   7
SER A   6
VAL A  72
PHE A  70
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
PHE A 480
LEU A 638
SER A 692
THR A 586
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7btf NSP12
(SARS-CoV-2)		4 / 7
PHE A 287
GLU A 254
THR A 246
PHE A 321
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
PHE A 287
GLU A 254
THR A 246
PHE A 321
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 7
PHE A 368
LEU A 372
SER A 520
VAL B  83
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
LEU A 187
GLU A 254
THR A 248
PHE A 317
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
LEU A 351
SER A 664
THR A 538
VAL A 535
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		7bv1 NSP12
NSP8
(SARS-CoV-2)		5 / 9
LEU B  91
SER A 384
VAL A 330
VAL A 342
LEU B 117
1.46A18.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ZNC_A_QI9A301_0
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		7bv1 NSP12
(SARS-CoV-2)		5 / 9
VAL A 667
SER A 681
VAL A 557
MET A 542
ASP A 623
1.71A14.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
NSP8
(SARS-CoV-2)		4 / 7
PHE B  92
LEU B  95
VAL A 335
PHE A 334
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
PHE A 480
LEU A 638
SER A 692
THR A 586
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_A_QI9A602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
NSP8
(SARS-CoV-2)		5 / 9
LEU B  91
SER A 384
VAL A 330
VAL A 342
LEU B 117
1.25A18.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
PHE A 287
GLU A 254
THR A 246
PHE A 321
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
(SARS-CoV-2)		4 / 7
SER A 451
THR A 556
VAL A 410
PHE A 442
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNV_D_QI9D602_0
(CYTOCHROME P450 2D6)		7bv2 NSP12
NSP8
(SARS-CoV-2)		4 / 7
PHE A 368
LEU A 372
SER A 520
VAL B  83
1.65A
None